DISCLAIMER: GOLDINVESTMENTCOMPANIES.COM IS AN AFFILIATED PARTNER FOR GOLDCO PRECIOUS METALS, AUGUSTA PRECIOUS METALS, AND BIRCH GOLD GROUP, PROMOTING THEIR GOLD IRA, GOLD 401K TRANSFER AND BITCOIN IRA SERVICES AND PRODUCTS.
BioHarvest Sciences (CSE: BHSC,FSE: 8MV) trademarked its proprietary non-GMO #Biotech platform technology called “Bio-Plant CELLicitation™,” which replaces “BioFarming” and underscores the potential for the technology to be used in the botanical drugs space. #BioHarvest CEO Ilan Sobel explains how the company is disrupting the marketplace with unique products and therapeutic solutions.
The company’s platform technology, Bio-Plant CELLicitation™, aims to combine actions of growing plant cells in industrial-scale bioreactors and elicit specific molecules to produce unique botanical compounds with high human utility value.
“We’ve developed over the last 12 years, worth close to $15 million in investment. We’re able to grow full spectrum, non-GMO cannabis without actually growing the plant or from the cell, which is the uniqueness of the platform technology. We can play in so many different areas, not just nutraceuticals not just the cannabinoid space, but in many other areas where we’re able to bring the power of the plant to the people,” said Sobel.
According to Sobel, they were able to really validate their ability to drive significant improvement in consumers’ overall health and wellness. BioHarvest is operating in the polyphenol antioxidant world with a unique product called Vinia. Vinia ® prevents lipid oxidation, protects the body by preventing oxidative damage to the cells, and reduces oxidation of LDL cholesterol.
BioHarvest also plans to build a production facility in Canada, as part of the next phase in the global expansion of its Cannabis vertical. It is exploring opportunities to acquire an existing licensed facility or a Licensed Producer, which would enable the Company to use its BioFarming technology to produce and then sell unique cannabis products into the Canadian market.
“We all believe there’s a significant upside as we drive that ambition of being a multi billion dollar biotech company, leveraging the power of our platform technology across multiple verticals. We will disrupt current industries by bringing unique products and therapeutic solutions to the marketplace, with consistency, purity, and sustainability credentials that are unique.”
Investing News Network (INN)
Find out more about investing by INN @
Want a FREE investor kit? Download here↓
Follow us Facebook:
Follow us on Twitter:
The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.